Developer docs
API playgroundTry for free, no card

Search company profiles

Qatar Biomedical Research Institute

Full company profile

uuid00hhfxz

Namestring
Qatar Biomedical Research Institute
Legal namestring
Qatar Biomedical Research Institute
Websiteurl
hbku.edu.qa
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Qatar Biomedical Research Institute (QBRI) is a biomedical research institute established in 2012 and operating within Hamad Bin Khalifa University (HBKU) on the Education City campus in Doha, Qatar. QBRI is part of the Qatar Foundation ecosystem and conducts basic and applied research aimed at improving disease prevention, diagnosis, and treatment for health priorities in Qatar and the broader Arab region. The institute is organized around three specialized research centers: the Diabetes Research Center, focused on a condition affecting approximately 20% of Qataris; the Translational Oncology Research Center, developing diagnostic and treatment tools with emphasis on breast cancer; and the Neurological Disorders Research Center, focused on autism spectrum disorder and related conditions of rising regional prevalence. QBRI also runs a Summer Research Program providing intensive biomedical research training to undergraduate students.

QBRI's operating model is that of a non-profit university research institution rather than a commercial enterprise. It is funded through institutional research grants from Qatar Foundation and aligned government entities, and it has no disclosed commercial pricing or products. Its distribution channels are academic: peer-reviewed publications, conference presentations, collaborations with international research institutions, and policy advisory work with the Qatar Ministry of Public Health. Its named external collaborators include Hamad Medical Corporation for clinical research, the Ministry of Public Health for national surveys on developmental disabilities, and a network of international research partners. A Scientific Advisory Committee of elite external scientists provides governance over research quality and direction.

The institute serves 51-100 employees including principal investigators, researchers, and summer program participants, and contributes to HBKU's broader research output of 210,000+ citations and 8,300+ publications. QBRI's customer base is essentially governmental and quasi-governmental: Qatar Foundation, the Ministry of Public Health, and Hamad Medical Corporation represent the principal demand for its research outputs, with secondary engagement from undergraduate students and regional healthcare institutions. There is no evidence of commercial revenue generation, equity funding, M&A activity, or productized offerings in the input data.

Short descriptiontext

Qatar Biomedical Research Institute is a non-profit biomedical research institute within Hamad Bin Khalifa University and Qatar Foundation. It operates three centers (Diabetes, Oncology, Neurological Disorders) addressing regional health priorities in Qatar and the wider Arab region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDoha, Qatar
HQ citystring
Doha
HQ countrystring
Qatar
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research, diabetes research, cancer research, neurological disorders research, translational medicine
Industry3 codes
1National Public Health Reference Laboratories
CodeHLAJAIAAPrimaryYes
2Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
3Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
CodeHLACAOAMPrimaryNo
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Institutional Research Funding
TypeSubscription Recurring
Description

As a research institute under Hamad Bin Khalifa University, QBRI operates as a non-profit educational research institution supported by institutional funding from Qatar Foundation and government research grants. The institute conducts research to improve healthcare in Qatar through new discoveries in prevention, diagnosis, and treatment of diseases.

hbku.edu.qa
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

QBRI is a multidisciplinary biomedical research institute operating three specialized centers—the Diabetes Research Center, the Translational Oncology Research Center, and the Neurological Disorders Research Center—focused on developing prevention, diagnosis, and treatment strategies for diseases with high prevalence in Qatar and the broader region. The institute conducts basic and applied research, translates discoveries into clinical applications, and runs the Summer Research Program to train undergraduate students.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Contributing to HBKU's 210,000+ citations and 8,300+ publications across the university
+1 more record
Product overview1 text field

Qatar Biomedical Research Institute (QBRI) is a research institute within Hamad Bin Khalifa University operating as a multidisciplinary biomedical research facility. QBRI comprises three specialized research centers: the Diabetes Research Center, focusing on diabetes prevention, diagnosis, and treatment strategies; the Translational Oncology Research Center, developing diagnostic tools and cancer treatments with emphasis on breast cancer; and the Neurological Disorders Research Center, exploring autism and other neurological conditions prevalent in the region. The institute also offers a Summer Research Program for undergraduate students. QBRI's mission centers on advancing healthcare through cutting-edge research and translating scientific discoveries into clinical applications, particularly for diseases affecting Qatar and the MENA region.

Product and service5 records
1QBRI Biomedical Research Programs
CategoryBiomedical research institute offering
Description

A multidisciplinary biomedical research offering dedicated to improving healthcare in Qatar and the region through discoveries in the prevention, diagnosis, and treatment of diseases, serving Qatar's national healthcare priorities and academic collaborators.

2Diabetes Research Center
CategoryResearch center
Description

A specialized research center focused on applying research findings to develop strategies for the prevention, diagnosis, and treatment of diabetes and related metabolic disorders in Qatar and beyond.

3Translational Oncology Research Center
CategoryResearch center
Description

A specialized research center developing diagnostic tools and treatment strategies to improve cancer patient care, with particular focus on breast cancer—the most common cancer among women globally—and cancers prevalent in Qatar and the region.

4Neurological Disorders Research Center
CategoryResearch center
Description

A specialized research center focused on exploring neurological disorders with increasing prevalence in Qatar and the broader region, particularly autism spectrum disorder.

5QBRI Summer Research Program
CategoryEducational / research training program
Description

An intensive research opportunity for outstanding undergraduate students providing hands-on research experience in various medical science fields, offered as part of QBRI's training and capacity-building mission.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

QBRI is a member institute of Hamad Bin Khalifa University, operating within the university's Education City campus. The institute benefits from HBKU's academic infrastructure, interdisciplinary research environment, and administrative support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

As part of HBKU which is a member of Qatar Foundation, QBRI benefits from the foundation's ecosystem of education and research institutions, including access to shared facilities and collaborative opportunities across Education City.

3Healthcare Institutions in Qatar
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaborations with Hamad Medical Corporation and other healthcare providers for clinical research initiatives, including the national survey on developmental disabilities diagnostics and interventions conducted with Ministry of Public Health.

hbku.edu.qa
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnerships with prestigious national and international institutions for long-term collaborations, knowledge sharing, and joint research programs in biomedical sciences.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaborative initiatives including national surveys on developmental disabilities, contributing to evidence-based healthcare policy development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major U.S. biomedical and genomic research institute operating at vastly larger scale; comparable to QBRI in disease research focus areas (cancer, diabetes/metabolic disease) but with substantially broader capabilities.

TypeBroad incumbent
Description

One of Europe's largest biomedical research institutes covering cancer, neuroscience, and immunology, serving as an analogous flagship national biomedical research center to QBRI but at substantially larger scale.

TypeBroad incumbent
Description

Sweden's premier medical university with extensive biomedical research programs across cancer, neuroscience, and metabolic diseases — representing a much larger, globally recognized peer in the same research category.

TypeBroad incumbent
Description

Global biomedical research network with deep expertise in infectious disease and public health, representing a much larger established player in the same biomedical research category as QBRI.

TypeDirect peer
Description

UK-based genomics and biomedical research institute conducting large-scale research in cancer, infectious disease, and population genetics — closely aligned to QBRI's translational research scope.

TypeDirect peer
Description

Also based in Qatar's Education City, Sidra Medicine combines biomedical research with clinical care across women's and children's health, making it the most direct peer in scope and geography to QBRI.

TypeBroad incumbent
Description

Japan's flagship national research institute covering life sciences, biomedical, and translational research — directly analogous to QBRI as a government-backed multidisciplinary biomedical research organization, though at far greater scale.

TypeDirect peer
Description

Operates as Qatar's principal medical research and education institution with strong U.S. medical school affiliation, overlapping with QBRI's biomedical research mission and sharing the same Education City ecosystem.

TypeDirect peer
Description

Saudi Arabia's national biomedical research arm under the Ministry of National Guard, conducting translational research across genomics, oncology, and metabolic diseases — directly comparable to QBRI's mission scope.

TypeDirect peer
Description

Saudi Arabia's flagship research hospital combining clinical care with biomedical research programs in cancer, genetics, and translational medicine — a comparable GCC biomedical research model to QBRI.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qatar Biomedical Research Institute

Biomedical Research Serviceshbku.edu.qa

Qatar Biomedical Research Institute is a non-profit biomedical research institute within Hamad Bin Khalifa University and Qatar Foundation. It operates three centers (Diabetes, Oncology, Neurological Disorders) addressing regional health priorities in Qatar and the wider Arab region.

What Qatar Biomedical Research Institute does

Qatar Biomedical Research Institute (QBRI) is a biomedical research institute established in 2012 and operating within Hamad Bin Khalifa University (HBKU) on the Education City campus in Doha, Qatar. QBRI is part of the Qatar Foundation ecosystem and conducts basic and applied research aimed at improving disease prevention, diagnosis, and treatment for health priorities in Qatar and the broader Arab region. The institute is organized around three specialized research centers: the Diabetes Research Center, focused on a condition affecting approximately 20% of Qataris; the Translational Oncology Research Center, developing diagnostic and treatment tools with emphasis on breast cancer; and the Neurological Disorders Research Center, focused on autism spectrum disorder and related conditions of rising regional prevalence. QBRI also runs a Summer Research Program providing intensive biomedical research training to undergraduate students.

QBRI's operating model is that of a non-profit university research institution rather than a commercial enterprise. It is funded through institutional research grants from Qatar Foundation and aligned government entities, and it has no disclosed commercial pricing or products. Its distribution channels are academic: peer-reviewed publications, conference presentations, collaborations with international research institutions, and policy advisory work with the Qatar Ministry of Public Health. Its named external collaborators include Hamad Medical Corporation for clinical research, the Ministry of Public Health for national surveys on developmental disabilities, and a network of international research partners. A Scientific Advisory Committee of elite external scientists provides governance over research quality and direction.

The institute serves 51-100 employees including principal investigators, researchers, and summer program participants, and contributes to HBKU's broader research output of 210,000+ citations and 8,300+ publications. QBRI's customer base is essentially governmental and quasi-governmental: Qatar Foundation, the Ministry of Public Health, and Hamad Medical Corporation represent the principal demand for its research outputs, with secondary engagement from undergraduate students and regional healthcare institutions. There is no evidence of commercial revenue generation, equity funding, M&A activity, or productized offerings in the input data.

Qatar Biomedical Research Institute firmographics

Firmographics
Name
Qatar Biomedical Research Institute
Legal name
Qatar Biomedical Research Institute
Website
https://hbku.edu.qa
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Qatar Biomedical Research Institute is a non-profit biomedical research institute within Hamad Bin Khalifa University and Qatar Foundation. It operates three centers (Diabetes, Oncology, Neurological Disorders) addressing regional health priorities in Qatar and the wider Arab region.
Ownership category
akta.pro rank

Qatar Biomedical Research Institute industry classification

Industry
Product category
Biomedical Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
National Public Health Reference Laboratories (HLAJAIAA)
akta.pro secondary industries
Clinical Research & Trial Central Laboratories (HLAFAMAL), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

  • Biomedical research
  • Diabetes research
  • Cancer research
  • Neurological disorders research
  • Translational medicine

Where Qatar Biomedical Research Institute is headquartered

Location

Headquarters

HQ city
Doha
HQ country
Qatar
HQ region
Middle East

Offices1 record

Markets served

Qatar Biomedical Research Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Institutional Research Funding: As a research institute under Hamad Bin Khalifa University, QBRI operates as a non-profit educational research institution supported by institutional funding from Qatar Foundation and government research grants. The institute conducts research to improve healthcare in Qatar through new discoveries in prevention, diagnosis, and treatment of diseases.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Qatar Biomedical Research Institute product offering

Product offering

Core offering

QBRI is a multidisciplinary biomedical research institute operating three specialized centers—the Diabetes Research Center, the Translational Oncology Research Center, and the Neurological Disorders Research Center—focused on developing prevention, diagnosis, and treatment strategies for diseases with high prevalence in Qatar and the broader region. The institute conducts basic and applied research, translates discoveries into clinical applications, and runs the Summer Research Program to train undergraduate students.

Product overview

Qatar Biomedical Research Institute (QBRI) is a research institute within Hamad Bin Khalifa University operating as a multidisciplinary biomedical research facility. QBRI comprises three specialized research centers: the Diabetes Research Center, focusing on diabetes prevention, diagnosis, and treatment strategies; the Translational Oncology Research Center, developing diagnostic tools and cancer treatments with emphasis on breast cancer; and the Neurological Disorders Research Center, exploring autism and other neurological conditions prevalent in the region. The institute also offers a Summer Research Program for undergraduate students. QBRI's mission centers on advancing healthcare through cutting-edge research and translating scientific discoveries into clinical applications, particularly for diseases affecting Qatar and the MENA region.

Differentiator

Problem solved

Functional benefit

Products and services

  • QBRI Biomedical Research Programs A multidisciplinary biomedical research offering dedicated to improving healthcare in Qatar and the region through discoveries in the prevention, diagnosis, and treatment of diseases, serving Qatar's national healthcare priorities and academic collaborators.
  • Diabetes Research Center A specialized research center focused on applying research findings to develop strategies for the prevention, diagnosis, and treatment of diabetes and related metabolic disorders in Qatar and beyond.
  • Translational Oncology Research Center A specialized research center developing diagnostic tools and treatment strategies to improve cancer patient care, with particular focus on breast cancer—the most common cancer among women globally—and cancers prevalent in Qatar and the region.
  • Neurological Disorders Research Center A specialized research center focused on exploring neurological disorders with increasing prevalence in Qatar and the broader region, particularly autism spectrum disorder.
  • QBRI Summer Research Program An intensive research opportunity for outstanding undergraduate students providing hands-on research experience in various medical science fields, offered as part of QBRI's training and capacity-building mission.

Quantifiable outcome

  • Contributing to HBKU's 210,000+ citations and 8,300+ publications across the university
  • +1 more outcomes

Companies that use Qatar Biomedical Research Institute

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Qatar Biomedical Research Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Qatar Biomedical Research Institute partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and major.

  • Hamad Bin Khalifa University (Parent Institution)coreStrategic or Co-development PartnerQBRI is a member institute of Hamad Bin Khalifa University, operating within the university's Education City campus. The institute benefits from HBKU's academic infrastructure, interdisciplinary research environment, and administrative support.
  • Qatar FoundationcoreStrategic or Co-development PartnerAs part of HBKU which is a member of Qatar Foundation, QBRI benefits from the foundation's ecosystem of education and research institutions, including access to shared facilities and collaborative opportunities across Education City.
  • Healthcare Institutions in QatarmajorStrategic or Co-development PartnerCollaborations with Hamad Medical Corporation and other healthcare providers for clinical research initiatives, including the national survey on developmental disabilities diagnostics and interventions conducted with Ministry of Public Health.
  • International Research InstitutionsmajorStrategic or Co-development PartnerPartnerships with prestigious national and international institutions for long-term collaborations, knowledge sharing, and joint research programs in biomedical sciences.
  • Ministry of Public Health (Qatar)majorStrategic or Co-development PartnerCollaborative initiatives including national surveys on developmental disabilities, contributing to evidence-based healthcare policy development.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Qatar Biomedical Research Institute competitors and assessment

Company assessment

Broad incumbents

  • Broad Institute of MIT and Harvard: Major U.S. biomedical and genomic research institute operating at vastly larger scale; comparable to QBRI in disease research focus areas (cancer, diabetes/metabolic disease) but with substantially broader capabilities.
  • Francis Crick Institute: One of Europe's largest biomedical research institutes covering cancer, neuroscience, and immunology, serving as an analogous flagship national biomedical research center to QBRI but at substantially larger scale.
  • Karolinska Institutet: Sweden's premier medical university with extensive biomedical research programs across cancer, neuroscience, and metabolic diseases — representing a much larger, globally recognized peer in the same research category.
  • Pasteur Institute: Global biomedical research network with deep expertise in infectious disease and public health, representing a much larger established player in the same biomedical research category as QBRI.
  • RIKEN: Japan's flagship national research institute covering life sciences, biomedical, and translational research — directly analogous to QBRI as a government-backed multidisciplinary biomedical research organization, though at far greater scale.

Direct peers

  • Wellcome Sanger Institute: UK-based genomics and biomedical research institute conducting large-scale research in cancer, infectious disease, and population genetics — closely aligned to QBRI's translational research scope.
  • Sidra Medicine: Also based in Qatar's Education City, Sidra Medicine combines biomedical research with clinical care across women's and children's health, making it the most direct peer in scope and geography to QBRI.
  • Weill Cornell Medicine-Qatar: Operates as Qatar's principal medical research and education institution with strong U.S. medical school affiliation, overlapping with QBRI's biomedical research mission and sharing the same Education City ecosystem.
  • King Abdullah International Medical Research Center (KAIMRC): Saudi Arabia's national biomedical research arm under the Ministry of National Guard, conducting translational research across genomics, oncology, and metabolic diseases — directly comparable to QBRI's mission scope.
  • King Faisal Specialist Hospital and Research Centre: Saudi Arabia's flagship research hospital combining clinical care with biomedical research programs in cancer, genetics, and translational medicine — a comparable GCC biomedical research model to QBRI.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Qatar Biomedical Research Institute social profiles

Digital presence

Qatar Biomedical Research Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qatar Biomedical Research Institute leadership team

Management profile

Number of profiles

Profiles1 record

Qatar Biomedical Research Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qatar Biomedical Research Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qatar Biomedical Research Institute

What does Qatar Biomedical Research Institute do?

QBRI is a multidisciplinary biomedical research institute operating three specialized centers—the Diabetes Research Center, the Translational Oncology Research Center, and the Neurological Disorders Research Center—focused on developing prevention, diagnosis, and treatment strategies for diseases with high prevalence in Qatar and the broader region. The institute conducts basic and applied research, translates discoveries into clinical applications, and runs the Summer Research Program to train undergraduate students.

Is Qatar Biomedical Research Institute a public or private company?

Qatar Biomedical Research Institute is a private company. It is classified as state government owned and is currently operating.

When was Qatar Biomedical Research Institute founded?

Qatar Biomedical Research Institute was founded in 2012. It employs 51 to 100 people.

Where is Qatar Biomedical Research Institute based?

Qatar Biomedical Research Institute is headquartered in Doha, Qatar, in the Middle East region.

How does Qatar Biomedical Research Institute make money?

One revenue line is on record: institutional Research Funding.

Who are Qatar Biomedical Research Institute's main competitors?

Broad incumbents on record are Broad Institute of MIT and Harvard, Francis Crick Institute, Karolinska Institutet, Pasteur Institute and RIKEN. Direct peers are Wellcome Sanger Institute, Sidra Medicine, Weill Cornell Medicine-Qatar, King Abdullah International Medical Research Center (KAIMRC) and King Faisal Specialist Hospital and Research Centre.

Does Qatar Biomedical Research Institute have an API?

No public API is recorded for Qatar Biomedical Research Institute.

What industry is Qatar Biomedical Research Institute in?

Qatar Biomedical Research Institute's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAJAIAA, National Public Health Reference Laboratories, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Peninsula NewspaperHBKU ‘mini-brain’ research offers hope for autism therapiesResearchers at Qatar Biomedical Research Institute are growing individual-specific brain organoids from blood cells of people with autism to study disease mechanisms and screen drugs. The platform aims to enable personalized treatments by testing compounds on these models before clinical use. The team plans to scale the platform across more individuals to identify both personalized and common therapeutic pathways.PR NewswireLe Qatar Biomedical Research Institute de l'université Hamad Bin Khalifa forme un nouveau partenariat avec le Harvard Stem Cell InstituteQatar Biomedical Research Institute (QBRI) at Hamad Bin Khalifa University has signed a five-year collaborative research and training agreement with the Harvard Stem Cell Institute (HSCI) in the United States. The partnership aims to advance stem cell biology research and develop viable treatments for diabetes by producing insulin-producing cells for both Type 1 and Type 2 patients. Clinical trials arising from this research will be conducted in collaboration with Hamad Medical Corporation and Sidra Medicine in Qatar.PR NewswireDas Qatar Biomedical Research Institute der der Hamad Bin Khalifa University geht neue Partnerschaft mit dem Harvard Stem Cell Institute einDas Qatar Biomedical Research Institute (QBRI) der Hamad Bin Khalifa University in Katar hat eine fünfjährige Vereinbarung über gemeinsame Forschung und Lehre mit dem Harvard Stem Cell Institute (HSCI) in Boston unterzeichnet. Die Initiative umfasst Fachausbildung und Forschung im Bereich der Stammzellbiologie mit dem Ziel, das erste Zelltherapieprogramm der Region zur Behandlung von Diabetes zu entwickeln. Klinische Studien, die aus dieser Zusammenarbeit entstehen, sollen in Zusammenarbeit mit der Hamad Medical Corporation und dem Sidra-Medicine-Krankenhaus in Katar durchgeführt werden.PR NewswireHamad Bin Khalifa University's Qatar Biomedical Research Institute Forms New Partnership With Harvard Stem Cell InstituteQatar Biomedical Research Institute (QBRI) under Hamad Bin Khalifa University has signed a five-year collaborative research and training agreement with the Harvard Stem Cell Institute to advance stem cell biology for diabetes treatments. The partnership aims to establish the region's first cell-therapy program by leveraging HSCI's expertise in producing insulin-producing cells. Clinical trials arising from this collaboration will involve local stakeholders including Hamad Medical Corporation and Sidra Medicine.